Most read article(s)

Article
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
Saúl Reyes, Ide Smets, David Holden, et al.

August 21, 2020
Views & Reviews
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
Kazuo Fujihara, Jeffrey L. Bennett, Jerome de Seze, et al.

August 20, 2020
Clinical/Scientific Notes
COVID-19—White matter and globus pallidum lesionsDemyelination or small-vessel vasculitis?
Gilles Brun, Jean-François Hak, Stéphanie Coze, et al.

May 22, 2020
Article
P2Y12 expression and function in alternatively activated human microglia
Craig S. Moore, Ariel R. Ase, Angham Kinsara, et al.

March 19, 2015
Article
Interleukin-26, preferentially produced by T_H17 lymphocytes, regulates CNS barrier function
Bieke Broux, Stephanie Zandee, Elizabeth Gowing, et al.

August 11, 2020
Article
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
Moli Fan, Wei Qiu, Bitao Bu, et al.

June 04, 2020
Article
Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?
Adil Maarouf, Audrey Rico, Clemence Boutiere, et al.

June 25, 2020
Clinical/Scientific Notes
COVID-19-associated acute necrotizing myelitis
Javier Sotoca, Yensa Rodríguez-Álvarez

June 10, 2020
Clinical/Scientific Notes
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, et al.

May 05, 2020
Article
EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MS
Gisella Guerrera, Serena Ruggieri, Mario Picozza, et al.

August 17, 2020

Pages